161 related articles for article (PubMed ID: 8313349)
1. Enhanced activity of CMP-neuAc:Gal beta 1-4GlcNAc:alpha 2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients.
Gessner P; Riedl S; Quentmaier A; Kemmner W
Cancer Lett; 1993 Dec; 75(3):143-9. PubMed ID: 8313349
[TBL] [Abstract][Full Text] [Related]
2. Increased CMP-NeuAc:Gal beta 1,4GlcNAc-R alpha 2,6 sialyltransferase activity in human colorectal cancer tissues.
Dall'Olio F; Malagolini N; di Stefano G; Minni F; Marrano D; Serafini-Cessi F
Int J Cancer; 1989 Sep; 44(3):434-9. PubMed ID: 2476402
[TBL] [Abstract][Full Text] [Related]
3. Donor substrate specificities of Gal beta 1,4GlcNAc alpha 2,6-sialyltransferase and Gal beta 1,3GalNAc alpha 2,3-sialyltransferase: comparison of N-acetyl and N-glycolylneuraminic acids.
Hamamoto T; Kurosawa N; Lee YC; Tsuji S
Biochim Biophys Acta; 1995 May; 1244(1):223-8. PubMed ID: 7766662
[TBL] [Abstract][Full Text] [Related]
4. Purification of a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase and a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase to homogeneity from rat liver.
Weinstein J; de Souza-e-Silva U; Paulson JC
J Biol Chem; 1982 Nov; 257(22):13835-44. PubMed ID: 7142179
[TBL] [Abstract][Full Text] [Related]
5. Human liver and human placenta both contain CMP-NeuAc:Gal beta 1-->4GlcNAc-R alpha 2-->3- as well as alpha 2-->6-sialyltransferase activity.
Nemansky M; Schiphorst WE; Koeleman CA; Van den Eijnden DH
FEBS Lett; 1992 Nov; 312(1):31-6. PubMed ID: 1426235
[TBL] [Abstract][Full Text] [Related]
6. Branch specificity of bovine colostrum CMP-sialic acid: Gal beta 1----4GlcNAc-R alpha 2----6-sialyltransferase. Sialylation of bi-, tri-, and tetraantennary oligosaccharides and glycopeptides of the N-acetyllactosamine type.
Joziasse DH; Schiphorst WE; Van den Eijnden DH; Van Kuik JA; Van Halbeek H; Vliegenthart JF
J Biol Chem; 1987 Feb; 262(5):2025-33. PubMed ID: 3546284
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of alpha (2-6)-sialyltransferase from human liver.
Sticher U; Gross HJ; Brossmer R
Glycoconj J; 1991 Feb; 8(1):45-54. PubMed ID: 1823612
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic characterization of CMP-NeuAc:Gal beta 1-4GlcNAc-R alpha(2-3)-sialyltransferase from human placenta.
Nemansky M; van den Eijnden DH
Glycoconj J; 1993 Feb; 10(1):99-108. PubMed ID: 8395270
[TBL] [Abstract][Full Text] [Related]
9. Action of rat liver Gal beta 1-4GlcNAc alpha(2-6)-sialyltransferase on Man beta 1-4GlcNAc beta-OMe, GalNAc beta 1-4GlcNAc beta-OMe, Glc beta 1-4GlcNAc beta-OMe and GlcNAc beta 1-4GlcNAc beta-OMe as synthetic substrates.
Hokke CH; van der Ven JG; Kamerling JP; Vliegenthart JF
Glycoconj J; 1993 Feb; 10(1):82-90. PubMed ID: 8358230
[TBL] [Abstract][Full Text] [Related]
10. Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases.
Petretti T; Kemmner W; Schulze B; Schlag PM
Gut; 2000 Mar; 46(3):359-66. PubMed ID: 10673297
[TBL] [Abstract][Full Text] [Related]
11. Release of sialyltransferases from rat liver Golgi membranes by a cathepsin D-like proteinase: comparison of the release of Gal beta 1-4GlcNAc alpha 2-6 sialyltransferase, Gal beta 1-3(4)GlcNAc alpha 2-3 sialyltransferase and lactosylceramide alpha 2-3 sialyltransferase (SAT-1).
Richardson K; Jamieson JC
Comp Biochem Physiol B Biochem Mol Biol; 1995 Feb; 110(2):445-50. PubMed ID: 7719647
[TBL] [Abstract][Full Text] [Related]
12. A solid-phase assay for the activity of CMPNeuAc:Gal beta 1-4GlcNAc-R alpha-2,6-sialyltransferase.
Mattox S; Walrath K; Ceiler D; Smith DF; Cummings RD
Anal Biochem; 1992 Nov; 206(2):430-6. PubMed ID: 1280007
[TBL] [Abstract][Full Text] [Related]
13. The polypeptide part of human chorionic gonadotrophin affects the kinetics of alpha 6-sialylation of its N-linked glycans but does not alter the branch specificity of CMP-NeuAc:Gal beta 1----4GlcNAc-R alpha 2----6-sialyltransferase.
Nemansky M; Edzes HT; Wijnands RA; Van den Eijnden DH
Glycobiology; 1992 Apr; 2(2):109-17. PubMed ID: 1606356
[TBL] [Abstract][Full Text] [Related]
14. Different sialyltransferase activities in human colorectal carcinoma cells from surgical specimens detected by specific glycoprotein and glycolipid acceptors.
Kemmner W; Krück D; Schlag P
Clin Exp Metastasis; 1994 May; 12(3):245-54. PubMed ID: 8194200
[TBL] [Abstract][Full Text] [Related]
15. The role of a cathepsin D-like activity in the release of Gal beta 1-4GlcNAc alpha 2-6-sialyltransferase from rat liver Golgi membranes during the acute-phase response.
Lammers G; Jamieson JC
Biochem J; 1988 Dec; 256(2):623-31. PubMed ID: 3146977
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
[TBL] [Abstract][Full Text] [Related]
17. Alterations of CMP-NeuAc:asialofetuin sialyltransferase activities in human colorectal adenocarcinoma.
Vázquez-Martín C; Gil-Martín E; Fernández-Briera A
Oncology; 2003; 64(1):74-82. PubMed ID: 12457034
[TBL] [Abstract][Full Text] [Related]
18. Transfer of synthetic sialic acid analogues to N- and O-linked glycoprotein glycans using four different mammalian sialyltransferases.
Gross HJ; Rose U; Krause JM; Paulson JC; Schmid K; Feeney RE; Brossmer R
Biochemistry; 1989 Sep; 28(18):7386-92. PubMed ID: 2510824
[TBL] [Abstract][Full Text] [Related]
19. Determination of the specificities of rat liver Gal(beta 1-4)GlcNAc alpha 2,6-sialyltransferase and Gal(beta 1-3/4)GlcNAc alpha 2,3-sialyltransferase using synthetic modified acceptors.
Wlasichuk KB; Kashem MA; Nikrad PV; Bird P; Jiang C; Venot AP
J Biol Chem; 1993 Jul; 268(19):13971-7. PubMed ID: 8314763
[TBL] [Abstract][Full Text] [Related]
20. Chronic ethanol downregulates Gal-beta-1,4GlcNAc alpha 2,6-sialyltransferase and Gal-beta-1,3GlcNAc alpha 2,3-sialyltransferase mRNAs in rat liver.
Rao MN; Lakshman MR
Alcohol Clin Exp Res; 1997 Apr; 21(2):348-51. PubMed ID: 9113274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
